Finzati - Logo
AKBA logo

Akebia Therapeutics, Inc.

AKBA • Biotechnology
$0.97
▼ -0.01 (-0.87%)
Current price
EarningsLatest report: Jun 30, 2026
WEAK PROFILEWeakConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Weak historical ratio profile. The current evidence does not support a favorable risk/reward view.
Market Cap
$262.78M
Growth
—
Cash Flow
1/5
Trend
Volatile
Evidence
Positive free cash flow · 0.26High debt level · 6.63Negative growth trendWeak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 7, 2026, 1:30 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.97
Change-0.87%
Shares Out269.60M
Market Cap$262.78M
Enterprise Value$156.80M
52W Range0.82 - 3.44
Beta0.24
P/E-8.86
P/S1.20
P/B10.50
P/FCF13.90
EV/Sales0.72

Investment DNA

How strong this company looks for long-term investors

38
out of 100
Business Quality
Margins, moat, returns
30/100
Financial Strength
Debt, cash, stability
41/100
Growth Potential
Revenue and expansion
20/100
Price Attractiveness
Cheap or expensive today
63/100
Why this score▼
Positive free cash flow · 0.26High debt level · 6.63Negative growth trendWeak profitability

Analyst view

Analyst sentiment and price target

AKBA
Analyst sentiment
Based on 12 analyst votes · 2026-09-05
75/100
Bullish
Bullish
7
Hold
4
Bearish
1
Price Target
2026-08-07
Low
$1.00
Mean
$1.00
Median
$1.00
High
$1.00

Company Overview

IPO: 3/20/2014
Industry: Biotechnology
P/B i: 10.50
Debt / Equity i: 6.63
Operating Margin: 9.95%
Net Margin: -2.26%
ROE i: -
ROIC: -

Financial Health

Score8 / 20
Debt / Equity: 6.63
Current Ratio: 1.13
Quick Ratio: 1.04
Status: Moderate

Warnings

  • High debt level

Insider Transactions

Recent executive and insider activity

⚠ 1 high-volume insider sell detected
Ostrowski Erik
Transaction: 06/29/2026
SELL
Change
-56,019
Price
$1.11
Filing
07/01/2026
Type
SELL
ADAMS ADRIAN
Transaction: 06/17/2026
BUY
Change
+53,600
Price
$1.02
Filing
06/22/2026
Type
BUY
ADAMS ADRIAN
Transaction: 06/17/2026
BUY
Change
+35,700
Price
Not reported
Filing
06/22/2026
Type
BUY